discontinued

GTX123105 C2orf84 antibody

See related secondary antibodies

Search for all "C2orf84"

0.1 ml / €220.00

Quick Overview

Rabbit anti C2orf84

Product Description for C2orf84

Rabbit anti C2orf84.
Presentation: Purified
Product is tested for Western blot / Immunoblot.

Properties for C2orf84

Product Category Primary Antibodies
Quantity 0.1 ml
Synonyms C2orf84, FLJ30851, chromosome 2 open reading frame 84
Presentation Purified
Applications WB
Clonality Polyclonal
Host Rabbit
Isotype IgG
Shipping to Europe only
PDF datasheet View Datasheet
Manufacturer GeneTex Inc.

Datasheet Extract

Immunogen
Swiss Prot Num:
Q86W67
Immunogen:
Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 172 (Q86W67) of C2orf84
GeneID:
653140
Add. information Target recombinant protein,
Application Dot
Concentration 1 mg/ml
Storage Keep as concentrated solution. Aliquot and store at -20degC or below. Avoid multiple freeze-thaw cycles.
Format
Buffer System:
0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
State:
Purified
Gene ID 653140

Accessory Products

Proteins and/or Positive Controls

Proteins for C2orf84 (1 products)

Catalog No. Species Pres. Purity   Source  

Chromosome 2 open reading frame 84 (C2orf84), full length, with N-terminal HIS tag, expressed in E. coli, 50ug (full length, N-term HIS tag)

Chromosome 2 open reading frame 84 (C2orf84), full length, with N-terminal HIS tag, expressed in E. coli, 50ug Human > 80 %
Preparation: .
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
E. coli
50 µg / €199.00
  OriGene Technologies, Inc.

Positive controls for C2orf84 (2 products)

Catalog No. Species Pres. Purity   Source  

C2orf84 Lysate

Western Blot: C2orf84 Lysate [NBL1-10762] - Western Blot experiments. 
Left-Control; Right -Over-expression Lysate for C2orf84
0.1 mg / €400.00
  Novus Biologicals Inc.

FAM228A overexpression lysate

FAM228A overexpression lysate
0.1 mg / €280.00
  OriGene Technologies, Inc.
  • LinkedIn